FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

26 Aug 2026 · 13:36 UTC

Observed price moves

ABT-0.70%15 min after this headline
DXCM+0.03%15 min after this headline
PODD+0.50%15 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next. We pay about $120,000 a month for the newswires behind this feed.